Juvenile Dermatomyositis (JDM) muscle arthritis
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Diagnosed juvenile Dermatomyositis, between 12- 18 years of age, clinical remission has been diagnosed by the attending physician, signed informed consent by patient and parents/ legal representatives. Inclusion criteria healthy subjects: healthy, active lifestyle, signed informed consent by subject and parents/ legal representatives
Exclusion criteria
Exclusion criteria: Diagnosed polymyositis or myositis with MCTD, active myositis, age 18 years, no informed consent Exclusion criteria healthy subjects: history of muscle disease, chronic medication usage, underlying auto-immune disease (e.g. JIA, SLE, MCTD), no informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| In 5 patients with JDM (and the 5 healthy controls) there will be studied whether there are difference demonstrable concerning the muscle energetics in the proximal leg muscles during a recumbent bicycle-exercise test in a MR scanner (using 31P MRS) as a measure for an efficient metabolism. The following parameters will be determined: (i) Phosphocreatin/ anorganic Phosphate (PCr/Pi) ratio at different levels of exercise load (ii) Glycolytic intermediary metabolite concentration (mono-phosphorylised glucose) during different levels of exercise load (iii) Acidity (pH value) at different levels of exercise load (iv) Energy usage (ATP turnover; mm/s) during different levels of exercise load (v) ATP buffer (PCr) re-synthesis speed during recovery after exercise | — |
Secondary
| Measure | Time frame |
|---|---|
| The ratios between the measured VO2 piek and CO2 piek are determined in relation to maximal power (Wmax), to describe a unit of measure for the so-called mechanical efficiency of the muscles. | — |
Countries
Netherlands